US FDA Panel Endorses Pfizer COVID-19 Booster Shots For People 65-Year-Old And Above
Faizan Hashmi Published September 18, 2021 | 02:30 AM
WASHINGTON (UrduPoint News / Sputnik - 18th September, 2021) An advisory panel to the US food and Drug Administration (FDA) on Friday voted unanimously to endorse Pfizer-BioNTech's COVID-19 booster shots for people who are 65 years and older, after rejecting approval of the shot for all Americans who were already vaccinated for the novel coronavirus.
"It's likely beneficial, in my opinion, for the elderly, and may eventually be indicated for the general population. I just don't think we're there yet in terms of the data," Ofer Levy, a vaccine and infectious disease specialist at Boston Children's Hospital who was among 18 medical professionals who held a live-streamed public discussion on the merits of the booster before voting on it, said.
The partial approval was a face-saving grace for the Biden administration, which had already announced it would begin distributing by September 20� boosters for all Americans who had previously received two shots of the Pfizer-BioNTech and Moderna vaccines and one shot of the Johnson & Johnson vaccine.
A total rejection of the booster would have put in jeopardy a key part of President Joe Biden's plan to combat COVID-19 and its more dangerous and transmissible Delta variant.
Earlier in the hearing, panel members overwhelmingly rejected the booster shot for younger people, citing the inadequacy of data samples that had been submitted for their consideration.
Aside from seniors, the panel approved the booster for anyone with a high risk of contracting a severe case of COVID-19.
It also also approved emergency use authorization rather than a supplemental approval of the already fully-licensed vaccine.
"There was a very small data set that was done in the third dose for Pfizer ... we really do need broader safety data,"� said Hayley Gans, a professor of pediatrics and pediatric infectious disease at Stanford University, who was among those who voted. "I would support having a third dose available for other high-risk groups, such as individuals over the age of 50 to 60."
Prior to the vote, Biden administration officials had cited three studies from the US Centers for Disease Control and Prevention that showed fully vaccinated people could still experience diminished immunity after several months. As such, the administration had planned to call people up to get a third dose of Pfizer or Moderna's vaccine eight months after their second shot.
Biden himself had said that scientists were reviewing whether to move the third shot up by three months.
Friday's vote considered analyses from not just Pfizer but also Moderna, which showed the incidence of breakthrough COVID-19 cases - occurring in fully vaccinated people - was less frequent in clinical trial participants who were more recently inoculated, suggesting that the initial protection from the vaccines waned over time.
Pfizer also submitted a study in Israel showing a third dose of the vaccine six months after a second shot restores protection from infection to 95%.
Recent Stories
Meezan Bank, Roche Pakistan join forces to combat breast cancer
Tamasha to livestream ICC men's T20 World Cup 2024
Pakistan and Japan Final clash in Azlan Shah Hockey Cup 2024 on Saturday
Reasons to experience magic of Sharjah Children’s Reading Festival this weeken ..
Eight unfrequented routes closed to secure Karachi
Paris officer 'between life and death' after police station shooting
Renowned journalist Mazhar Abbass unveils Abbottabad cricket trophy
Lists of farmers entitled to get gunny bags displayed at Passco purchase centers
DC Jhang visits DHQ Hospital, orders revamp, improved care
Regional head Federal Ombudsman visits NBP Shikarpur
CDA chief directs construction of cycling tracks in diplomatic enclave
Recovery of Ammunition by Customs at international Departure JIAP Karachi
More Stories From World
-
Reasons to experience magic of Sharjah Children’s Reading Festival this weekend
6 minutes ago -
Paris officer 'between life and death' after police station shooting
6 minutes ago -
Rafah offensive would lead to 'humanitarian disaster': UN chief
43 minutes ago -
Taylor Swift fever grips Paris at start of Europe tour
43 minutes ago -
S.Africa's top court hears critical Zuma election case
43 minutes ago -
Ukraine says Russia launches cross-border offensive in northeast
2 hours ago
-
Champion Rybakina, home hope Musetti retire sick from Rome Open
2 hours ago -
CPEC Phase II highlights strengthening bilateral cooperation in agriculture, industry, technology
2 hours ago -
Pandemic agreement talks near end with deal elusive
2 hours ago -
UK economy exits recession in pre-vote boost for PM Sunak
22 minutes ago -
Israeli artillery hits Rafah after truce talks end
2 hours ago -
Russia launches offensive into Kharkiv region: Ukraine
2 hours ago